Related Experiment Video
Updated: Aug 15, 2026
Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
Published on: March 22, 2012
Pulmonary infections complicating hematological disorders
Corrado Girmenia1, Pietro Martino
1Dipartimento di Biotecnologie Cellulari ed Ematologia, University La Sapienza, Rome, Italy.
Abstract:
Pulmonary infections are second in importance only to septicemia as a cause of infectious morbidity and mortality in patients with hematological disorders. The differential diagnosis of the pneumonitis syndrome includes not only infection but also a multitude of noninfectious causes. In addition, the diagnosis may be difficult, owing to the subtlety of the clinical signs as a consequence of the impaired inflammatory response. Radiographic findings are often nonspecific, and invasive procedures and microbiological exams are required to establish the cause of pulmonary disease and to choose a specific therapy. However, invasive diagnostic procedures are often precluded by the poor general conditions and (particularly in acute leukemia patients) by concurrent thrombocytopenia. The approach to all infectious complications, including those of the lower respiratory tract, in immunocompromised patients with hematological diseases, is based on aggressive prevention strategies and the empirical administration of broad-spectrum antimicrobials eventually followed by a clinically or microbiologically guided treatment modification. With regard to the antimicrobial treatment, given the variety of infectious and noninfectious causes of pulmonary infiltrates in patients with hematological diseases, the diversity of the underlying immunocompromised state, and the spectrum of clinical findings, no single general therapeutic algorithm can be applied.
Insights
Pulmonary infections are a major risk for patients with hematological disorders. Diagnosis and treatment are challenging due to non-specific symptoms and patient conditions, requiring tailored antimicrobial strategies.
Area of Science:
- Hematology
- Infectious Diseases
- Pulmonology
Background:
- Pulmonary infections are a significant cause of illness and death in patients with hematological disorders.
- Diagnosing pneumonitis in these patients is complex due to subtle clinical signs and non-specific radiographic findings.
- Impaired inflammatory responses and conditions like thrombocytopenia can hinder diagnostic procedures.
Purpose of the Study:
- To review the challenges in diagnosing and managing pulmonary diseases in immunocompromised patients with hematological disorders.
- To highlight the importance of prevention and empirical antimicrobial therapy.
- To discuss the limitations of a single therapeutic algorithm for pulmonary infiltrates.
Main Methods:
- Review of literature on pulmonary infections in hematological disorders.
- Discussion of diagnostic challenges and therapeutic approaches.
- Emphasis on empirical broad-spectrum antimicrobial administration.
Main Results:
- Pulmonary infections are a leading cause of infectious morbidity and mortality in hematological patients.
- Diagnosis is often difficult, requiring invasive procedures which may not be feasible.
- No universal treatment algorithm exists due to diverse causes and patient conditions.
Conclusions:
- Aggressive prevention and empirical broad-spectrum antimicrobials are key initial strategies.
- Treatment must be guided by clinical and microbiological findings.
- Individualized therapeutic approaches are necessary for pulmonary infiltrates in immunocompromised hematological patients.
Related Concept Videos
01:29Pneumonia I: Introduction
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
01:30Pneumonia III: Complications and Assessment
01:29Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:17Other Pulmonary Disorders